The price-to-earnings ratio for Chemed Corp. (NYSE: CHE) is above average at 30.86x. The 36-month beta value for CHE is also noteworthy at 0.43. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 1 rating it as “overweight,” 3 rating it as “hold,” and 0 rating it as “sell.”
The public float for CHE is 14.77M, and at present, short sellers hold a 2.96% of that float. The average trading volume of CHE on April 26, 2024 was 80.01K shares.
CHE) stock’s latest price update
Chemed Corp. (NYSE: CHE) has experienced a decline in its stock price by -7.22 compared to its previous closing price of 617.95. However, the company has seen a fall of -4.03% in its stock price over the last five trading days. Zacks Investment Research reported 2024-04-25 that Chemed’s (CHE) first-quarter 2024 results reflect VITAS’ impressive revenue growth and improved average revenues per patient per day.
CHE’s Market Performance
Chemed Corp. (CHE) has experienced a -4.03% fall in stock performance for the past week, with a -10.13% drop in the past month, and a -3.46% drop in the past quarter. The volatility ratio for the week is 2.52%, and the volatility levels for the past 30 days are at 1.58% for CHE. The simple moving average for the past 20 days is -7.75% for CHE’s stock, with a 0.99% simple moving average for the past 200 days.
Analysts’ Opinion of CHE
Many brokerage firms have already submitted their reports for CHE stocks, with RBC Capital Mkts repeating the rating for CHE by listing it as a “Outperform.” The predicted price for CHE in the upcoming period, according to RBC Capital Mkts is $535 based on the research report published on March 11, 2020 of the previous year 2020.
JMP Securities, on the other hand, stated in their research note that they expect to see CHE reach a price target of $490. The rating they have provided for CHE stocks is “Mkt Outperform” according to the report published on November 01st, 2019.
BofA/Merrill gave a rating of “Buy” to CHE, setting the target price at $500 in the report published on September 06th of the previous year.
CHE Trading at -7.91% from the 50-Day Moving Average
After a stumble in the market that brought CHE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -12.42% of loss for the given period.
Volatility was left at 1.58%, however, over the last 30 days, the volatility rate increased by 2.52%, as shares sank -11.01% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +0.28% upper at present.
During the last 5 trading sessions, CHE fell by -4.03%, which changed the moving average for the period of 200-days by +7.96% in comparison to the 20-day moving average, which settled at $617.95. In addition, Chemed Corp. saw -1.95% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CHE starting from LEE SPENCER S, who sale 2,000 shares at the price of $641.65 back on Mar 28 ’24. After this action, LEE SPENCER S now owns 20,760 shares of Chemed Corp., valued at $1,283,300 using the latest closing price.
Witzeman Michael D, the VP & Chief Financial Officer of Chemed Corp., sale 2,650 shares at $643.14 during a trade that took place back on Mar 21 ’24, which means that Witzeman Michael D is holding 2,882 shares at $1,704,321 based on the most recent closing price.
Stock Fundamentals for CHE
Current profitability levels for the company are sitting at:
- 0.15 for the present operating margin
- 0.35 for the gross margin
The net margin for Chemed Corp. stands at 0.12. The total capital return value is set at 0.24. Equity return is now at value 27.47, with 17.94 for asset returns.
Based on Chemed Corp. (CHE), the company’s capital structure generated 0.12 points at debt to capital in total, while cash flow to debt ratio is standing at 2.13. The debt to equity ratio resting at 0.14. The interest coverage ratio of the stock is 109.58.
Currently, EBITDA for the company is 403.69 million with net debt to EBITDA at -0.26. When we switch over and look at the enterprise to sales, we see a ratio of 3.78. The receivables turnover for the company is 12.48for trailing twelve months and the total asset turnover is 1.29. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.91.
Conclusion
In summary, Chemed Corp. (CHE) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
